For other salt forms please inquire. Selective and membrane-permeant inhibitor of both cyclic GMP dependent protein kinase I α and I β and of retinal cGMP-gated ion channels. Resistant against mammalian cyclic nucleotide-dependent phosphodiesterases, no metabolic side effects. More lipophilic and membrane-permeant compared to Rp-8-pCPT-cGMPS (Cat. No. C 013). Detailed technical information and updated reference list available on request. Reference: Butt et. al., Br. J. Pharmacol., 116, 3110 - 3116 (1995).
Cat. No. | P 007 |
CAS number | [172806-20-1] |
Purity | > 99% HPLC |
Salt form | Sodium |
Storage temperature | -20°C / -4°F |
Light-sensitive | True |
Molecular formula | C₁₈H₁₄BrN₅O₆PS · Na |
Molecular weight [g/mol] | 562.3 |
Modifications | 1-cGMP, 2-cGMP, 8-cGMP |
Target | PKG (cGK) Inhibitor |
Lipophilicity | 2.83 |
Absorption max [nm] | 256 |
Molar extinction coefficient ε [L·mol⁻¹·cm⁻¹] | 40000 |